Anti-ZDHC2/ ZDHHC2/ DHHC2 monoclonal antibody

Anti-ZDHC2/ ZDHHC2/ DHHC2 antibody for FACS & in-vivo assay

Target products collectionGo to ZDHHC2/ZDHHC2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1958-Ab-1/ GM-Tg-hg-MP1958-Ab-2Anti-Human ZDHHC2 monoclonal antibodyHuman
GM-Tg-rg-MP1958-Ab-1/ GM-Tg-rg-MP1958-Ab-2Anti-Rat ZDHHC2 monoclonal antibodyRat
GM-Tg-mg-MP1958-Ab-1/ GM-Tg-mg-MP1958-Ab-2Anti-Mouse ZDHHC2 monoclonal antibodyMouse
GM-Tg-cynog-MP1958-Ab-1/ GM-Tg-cynog-MP1958-Ab-2Anti-Cynomolgus/ Rhesus macaque ZDHHC2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1958-Ab-1/ GM-Tg-felg-MP1958-Ab-2Anti-Feline ZDHHC2 monoclonal antibodyFeline
GM-Tg-cang-MP1958-Ab-1/ GM-Tg-cang-MP1958-Ab-2Anti-Canine ZDHHC2 monoclonal antibodyCanine
GM-Tg-bovg-MP1958-Ab-1/ GM-Tg-bovg-MP1958-Ab-2Anti-Bovine ZDHHC2 monoclonal antibodyBovine
GM-Tg-equg-MP1958-Ab-1/ GM-Tg-equg-MP1958-Ab-2Anti-Equine ZDHHC2 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1958-Ab-1/ GM-Tg-hg-MP1958-Ab-2; GM-Tg-rg-MP1958-Ab-1/ GM-Tg-rg-MP1958-Ab-2;
GM-Tg-mg-MP1958-Ab-1/ GM-Tg-mg-MP1958-Ab-2; GM-Tg-cynog-MP1958-Ab-1/ GM-Tg-cynog-MP1958-Ab-2;
GM-Tg-felg-MP1958-Ab-1/ GM-Tg-felg-MP1958-Ab-2; GM-Tg-cang-MP1958-Ab-1/ GM-Tg-cang-MP1958-Ab-2;
GM-Tg-bovg-MP1958-Ab-1/ GM-Tg-bovg-MP1958-Ab-2; GM-Tg-equg-MP1958-Ab-1/ GM-Tg-equg-MP1958-Ab-2
Products NameAnti-ZDHHC2 monoclonal antibody
Formatmab
Target NameZDHHC2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-ZDHHC2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species ZDHC2/ ZDHHC2/ DHHC2 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1958
    Target NameZDHHC2
    Gene ID51201,70546,246326,710001,475610,101081038,536310,100053506
    Gene Symbol and Synonyms5730415P04Rik,6430583A19Rik,DHHC-2,DHHC2,srec,ZDHHC2,ZNF372
    Uniprot AccessionQ9UIJ5,Q9JKR5
    Uniprot Entry NameZDHC2_HUMAN,ZDHC2_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000104219
    Target ClassificationN/A

    The target: ZDHHC2, gene name: ZDHHC2, also named as DHHC2, ZNF372. Enables protein homodimerization activity and protein-cysteine S-palmitoyltransferase activity. Involved in several processes, including peptidyl-L-cysteine S-palmitoylation; regulation of protein catabolic process; and regulation of protein localization to plasma membrane. Located in Golgi apparatus and endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.